STENT HAVING A TACKY SILICONE COATING TO PREVENT STENT MIGRATION
    33.
    发明申请
    STENT HAVING A TACKY SILICONE COATING TO PREVENT STENT MIGRATION 审中-公开
    具有TACKY SILICONE涂层以防止移动的STENT

    公开(公告)号:US20140121747A1

    公开(公告)日:2014-05-01

    申请号:US14012469

    申请日:2013-08-28

    CPC classification number: A61F2/848 A61F2/95 A61L31/10 A61L31/14 C08L83/04

    Abstract: A stent having an inner surface and an outer surface, at least a portion of the outer surface of the stent comprising a tacky biocompatible coating comprising a tacky polymer material and to methods of delivering and deploying a stent using a tacky biocompatible coating comprising a tacky polymer material.

    Abstract translation: 具有内表面和外表面的支架,所述支架的外表面的至少一部分包括粘性生物相容性涂层,所述粘性生物相容性涂层包含粘性聚合物材料,以及使用粘性生物相容性涂层递送和展开支架的方法,所述粘性生物相容性涂层包含粘性聚合物 材料。

    Delivery devices and methods
    39.
    发明授权

    公开(公告)号:US11433223B2

    公开(公告)日:2022-09-06

    申请号:US16560664

    申请日:2019-09-04

    Abstract: Implementations of a delivery device and method are disclosed. One implementation is a delivery device comprising a flow chamber with an inlet port for receiving a fluid flow in the flow chamber, and an outlet port for exiting a material from the flow chamber. The flow chamber may include a formation portion in which a suspension of the material is formed, and a collection portion that directs the suspension toward and/or into the outlet port. An amount of the material may collect in the collection portion adjacent the outlet port. The device may further comprise an insertion port for permitting insertion of the material in the flow chamber, and/or a pusher operable to move the amount of material through the outlet port. Related devices and methods also are disclosed.

    Powder for achieving hemostasis
    40.
    发明授权

    公开(公告)号:US10786596B2

    公开(公告)日:2020-09-29

    申请号:US16245780

    申请日:2019-01-11

    Abstract: In various aspects, the present disclosure pertains to methods of treating or preventing bleeding at a tissue site comprising applying a chitosan powder composition to the tissue site. In various aspects, the present disclosure pertains to chitosan powder compositions for application to a tissue site, where the powder compositions comprise a chitosan salt, a crosslinked chitosan, a derivatized chitosan, or a combination thereof. In various aspects, the disclosure pertains to catheter assemblies, which are preloaded with a chitosan powder composition and which are configured to deliver the chitosan powder composition a tissue site.

Patent Agency Ranking